Literature DB >> 7554326

Antimicrobial activity of glycerine-ichthammol in otitis externa.

K Ahmed1, M L Roberts, P T Mannion.   

Abstract

The clinical efficacy of glycerine-ichthammol in otitis externa may be due to an anti-inflammatory action of ichthammol or a dehydrating effect of glycerine on the oedematous ear canal. Its antimicrobial activity, if any, against the common organisms in otitis externa is not well known. A study of the antibacterial property of glycerine-ichthammol as measured by a growth inhibition test and a modified cidal assay, showed inhibition of selected gram positive organisms (Streptococcus pyogenes and Staphylococcus aureus) by ichthammol and glycerine-ichthammol combination, but only negligible antibacterial activity against Pseudomonas aeruginosa and Escherichia coli. Candida albicans was also weakly inhibited. As the activity against gram negative organisms is minimal, incorporation of an anti-gram negative antibiotic such as gentamicin in the glycerine-ichthammol compound to enhance its antibacterial spectrum is suggested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554326     DOI: 10.1111/j.1365-2273.1995.tb01847.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  3 in total

1.  Effective treatment of acute otitis externa: a comparison of steroid antibiotic versus 10% ichthammol glycerine pack.

Authors:  B L Shrestha; I Shrestha; R C M Amatya; A Dhakal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-01

2.  The management of otitis externa: a randomised controlled trial of a glycerol and icthammol ribbon gauze versus topical antibiotic and steroid drops.

Authors:  Rachael Hornigold; Darren Gillett; Elina Kiverniti; Meredydd Harries
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-07       Impact factor: 2.503

3.  A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa.

Authors:  Ajmal Masood; Ioannis Moumoulidis; Shalina Ray; Om Chawla; Jaan Panesar
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-06       Impact factor: 3.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.